Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, June 21, 2018 · 452,612,527 Articles · 3+ Million Readers

Global Low Molecular Weight Heparin Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

PUNE, INDIA, March 9, 2018 /EINPresswire.com/ -- Summary

WiseGuyReports.com adds “Low Molecular Weight Heparin Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Low Molecular Weight Heparin Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Low Molecular Weight Heparin Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Major applications as follows:
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2580274-global-low-molecular-weight-heparin-market-data-survey-report-2025

Table of Contents

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 Aspen
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Sanofi-aventis
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Pfizer
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Opocrin
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 CSBIO
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Dongying Tiandong Pharmaceutical
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Changzhou Qianhong Bio-pharma
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Techdow
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Yantai Dongcheng Pharmaceutical Group
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application
4.1 Treatment of Venous Thromboembolism
4.1.1 Overview
4.1.2 Treatment of Venous Thromboembolism Market Size and Forecast
4.2 Complications of Pregnancy
4.2.1 Overview
4.2.2 Complications of Pregnancy Market Size and Forecast
4.3 Cardioversion of Atrial Fibrillation/Flutter
4.3.1 Overview
4.3.2 Cardioversion of Atrial Fibrillation/Flutter Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast

Continued....

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire